Cargando…

Peptide nano-blanket impedes fibroblasts activation and subsequent formation of pre-metastatic niche

There is evidence to suggest that the primary tumor induces the formation of a pre-metastatic niche in distal organs by stimulating the production of pro-metastatic factors. Given the fundamental role of the pre-metastatic niche in the development of metastases, interruption of its formation would b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yi, Ke, Peng, Bao, Xiaoyan, Wu, Honghui, Xia, Yiyi, Zhang, Zhentao, Zhong, Haiqing, Dai, Qi, Wu, Linjie, Wang, Tiantian, Lin, Mengting, Li, Yaosheng, Jiang, Xinchi, Yang, Qiyao, Lu, Yiying, Zhong, Xincheng, Han, Min, Gao, Jianqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132894/
https://www.ncbi.nlm.nih.gov/pubmed/35614076
http://dx.doi.org/10.1038/s41467-022-30634-8
Descripción
Sumario:There is evidence to suggest that the primary tumor induces the formation of a pre-metastatic niche in distal organs by stimulating the production of pro-metastatic factors. Given the fundamental role of the pre-metastatic niche in the development of metastases, interruption of its formation would be a promising strategy to take early action against tumor metastasis. Here we report an enzyme-activated assembled peptide FR17 that can serve as a “flame-retarding blanket” in the pre-metastatic niche specifically to extinguish the “fire” of tumor-supportive microenvironment adaption. We show that the in-situ assembled peptide nano-blanket inhibits fibroblasts activation, suppressing the remodeling of the metastasis-supportive host stromal tissue, and reversing vascular destabilization and angiogenesis. Furthermore, we demonstrate that the nano-blanket prevents the recruitment of myeloid cells to the pre-metastatic niche, regulating the immune-suppressive microenvironment. We show that FR17 administration effectively inhibits the formation of the pulmonary pre-metastatic niche and postoperative metastasis, offering a therapeutic strategy against pre-metastatic niche formation.